Tag: AZD1222

AstraZeneca resumes AZD1222 Covid-19 vaccine trials after brief pause

pharmanewsdaily- October 24, 2020

AstraZeneca said that clinical trials for the AZD1222 Covid-19 vaccine candidate, have resumed in various parts of the world after regulators across the US, UK, ... Read More

AstraZeneca finalizes AZD1222 Covid-19 vaccine candidate deal with EC

pharmanewsdaily- August 15, 2020

AstraZeneca said that it has finalized a deal with the European Commission (EC) for the delivery of up to 400 million doses of the AZD1222 ... Read More

COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response

pharmanewsdaily- July 20, 2020

COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001 clinical trial showed the ChAdOx1 nCoV-19 vaccine ... Read More

Catalent wins contract to manufacture AZD1222 COVID-19 vaccine candidate

pharmanewsdaily- June 16, 2020

US-based Catalent said that its subsidiary Catalent Biologics has bagged a contract to provide vial filling and packaging capacity to AstraZeneca at its manufacturing facility ... Read More